| Financial Year |
March 31 2023 |
| Monetary Funds |
477,936,823.65 |
| Held-for-trading Financial Assets |
280,000,000.00 |
| Notes Receivable |
1,150,000.00 |
| Accounts Receivable |
229,860,377.25 |
| Advances to Suppliers |
9,818,325.25 |
| Other Receivables |
9,765,874.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
30,459,618.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,442,407.76 |
| Total Current Assets |
1,059,439,256.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,815,727.11 |
| Investment Properties |
3,196,171.80 |
| Fixed Assetes |
197,634,939.18 |
| Under-construction Projects |
19,767,638.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,226,227.72 |
| R&D expenses |
57,706,077.95 |
| Goodwill |
31,166,300.36 |
| Long-Term Deferred and Prepaid Expenses |
3,899,515.73 |
| Deferred Income Tax Assets |
17,852,422.26 |
| Other Non-Current Assets |
362,646,904.28 |
| Sub-Total of Non-Current Assets |
755,847,363.35 |
| Total Assets |
1,815,286,619.69 |
| Short-Term Loans |
138,778,125.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
198,229,089.00 |
| Accounts Payable |
28,785,224.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,442,815.66 |
| Taxes Payable |
7,145,568.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,101,222.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,153,027.88 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
460,327,243.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
69,060.22 |
| Other Non-Current Liabilities |
976,471.07 |
| Sub-Total of Non-Current Liabilities |
6,946,905.06 |
| Total Liabilities |
467,274,148.14 |
| Paid-In Capital(Or Share Stock) |
235,841,478.00 |
| Capital Surplus |
808,960,859.72 |
| Surplus Reserve |
46,732,639.42 |
| LESS:Treasury Stock |
45,088,241.34 |
| Undistributed Profits |
301,640,838.13 |
| Minority Stockholder's Interest |
2,755,996.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,345,256,474.75 |
| Owner's Equity（Stockholder's Equity） |
1,348,012,471.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,815,286,619.69 |
